Acceleron Pharma Inc Margen de beneficio

¿Qué es el Margen de beneficio de Acceleron Pharma Inc?

El Margen de beneficio de Acceleron Pharma Inc es -226.01%

¿Cuál es la definición de Margen de beneficio?



El margen de ganancia es una medida de la rentabilidad. La misma se calcula al encontrar la ganancia neta como un porcentaje de los ingresos.

Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.

Margen de beneficio de compañías en Sector Health Care en NASDAQ en comparadas con Acceleron Pharma Inc

¿Qué hace Acceleron Pharma Inc?

Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.

Empresas con margen de beneficio similar a Acceleron Pharma Inc